AwardFares Launches Intelligent New Alert System for Award Flight Availability
5.8.2025 08:00:00 CEST | Business Wire | Press Release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/
AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights.
The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before.
Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on high-demand routes but also on high-value redemptions and new opportunities based on industry trends, fare dynamics, and user behavior patterns.
For travelers with a specific plan, Live Alerts offer precision monitoring. This enhanced version of the platform's original alert feature allows users to target exact flights and routes. A key improvement is the ability to monitor multiple airports and extended date ranges within a single alert, making it easier and more efficient to track down must-have award seats for a specific trip.
This launch reaffirms AwardFares' role as a product-driven leader in the industry. The company has a track record of introducing user-centric features that set new standards, including live availability checks, interactive seat maps, and its exclusive onboard menu and wine list feature.
"Our users loved setting alerts for specific routes and dates, and it worked wonderfully. But we are obsessed with user experience and saw an opportunity to take it further," says Philip, Co-Founder at AwardFares. "To truly maximize your points, you often need to broaden your perspective. An alert that's too specific might cause you to miss an incredible Business Class deal from a neighboring city or one with a simple connection. With the new Flex Alerts, we provide a broader perspective on award availability, highlighting opportunities users might never have discovered on their own. When combined with our precision Live Alerts, travelers can build a powerful strategy to capitalize on these great opportunities."
Continued Platform Expansion
Demonstrating its commitment to providing the most comprehensive search tool on the market, AwardFares highlighted the addition of several new loyalty programs throughout the year and plans to integrate more partners in the coming months. This expansion will focus on key strategic areas, including broadening its coverage within the Avios ecosystem and adding new airline programs based in Latin America. Underscoring this commitment to global accessibility, AwardFares is also the only award search tool available in Spanish, uniquely positioning it to serve travelers throughout the Spanish-speaking world.
How to Access
The new Live and Flex Alerts are available today for AwardFares Gold and Diamond members. For more information and to start a free trial, visit https://awardfares.com/.
About AwardFares
AwardFares is an innovative online platform that simplifies the complexities of finding and booking award flights. Born from the founders' frustration with existing tools, AwardFares offers a fast and user-friendly interface that enables travelers to search across multiple frequent flyer programs and airline alliances simultaneously. With powerful features like the Timeline View, Live Seat Maps, Onboard Menus, and now the new Live and Flex Alerts, AwardFares' mission is to save travelers time and help them maximize the value of their points and miles, turning dream trips into reality.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250804412041/en/
Contacts
Media Contact
Germán Ceballos
Head of Marketing
media@awardfares.com
+1 774 5459975
https://awardfares.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fawardfares.com
&esheet=54290175&newsitemid=20250804412041&lan=en-US&anchor=https%3A%2F%2Fawardf
ares.com&index=2&md5=27ff3b746f8d163e35875d149d127098
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom